ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.

ClinicalTrials.gov ID: NCT06517758

Public ClinicalTrials.gov record NCT06517758. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 20, 2026, 10:20 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy, Safety, and Tolerability of Iptacopan in Patients With Generalized Myasthenia Gravis, Followed by an Open-label Extension Phase

Study identification

NCT ID
NCT06517758
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
146 participants

Conditions and interventions

Interventions

  • Iptacopan Drug
  • Matching Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 85 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 30, 2024
Primary completion
Apr 29, 2027
Completion
May 26, 2032
Last update posted
May 13, 2026

2024 – 2032

United States locations

U.S. sites
19
U.S. states
13
U.S. cities
19
Facility City State ZIP Site status
Honor Health Research Institute Scottsdale Arizona 85258 Recruiting
Fullerton Neuro and Headache Ctr Fullerton California 92835 Recruiting
SC3 Research Pasadena Pasadena California 91105 Recruiting
California Pacific Medical Center Sacramento California 94115 Recruiting
Neurology Offices Of South Florida Boca Raton Florida 33428 Withdrawn
Superior Associates in Research LLC Hialeah Florida 33012 Withdrawn
Augusta University Georgia Augusta Georgia 30912 Recruiting
Hawaii Pacific Neuroscience LLC Honolulu Hawaii 96817 Withdrawn
University of Chicago Medical Centr Chicago Illinois 60637 Recruiting
Prairie Heart Institute Springfield Illinois 62769 Recruiting
Mid Atlantic Epilepsy and Sleep Ctr Bethesda Maryland 20817-1807 Recruiting
Duke University Medical Center Durham North Carolina 27710 Recruiting
Neuroscience Research Ctr Canton Ohio 44718 Withdrawn
Ohio State University Medical Center Columbus Ohio 43210 Withdrawn
Penn Presbyterian Medical Center Philadelphia Pennsylvania 19104 Recruiting
Vanderbilt University Medical CenterX Nashville Tennessee 37221 Recruiting
Nerve and Muscle Center of Texas Houston Texas 77030 Recruiting
Central TX Neuro Consultants P A Round Rock Texas 78681 Recruiting
Center for Neurological Disorders G Greenfield Wisconsin 53228-1321 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 94 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06517758, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 13, 2026 · Synced May 20, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06517758 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →